This conference has been withdrawn from the 2021 conference schedule.
Since the beginning of the pandemic, the GRC Board of Trustees and staff have been assessing the impacts of COVID-19 on our 2021 conference season. As always, our priority is to support and preserve our conference communities and their health and safety while continuing GRC's 90-year tradition of advancing the frontiers of science. In light of the uncertainties surrounding the pandemic, the GRC Board of Trustees surveyed your conference chair(s) to determine their preference to postpone the meeting to 2023 or reschedule to a date later in the 2021 season. Per the chair's request, the Board has deferred the meeting and removed it from the 2021 schedule. Thank you for your understanding, and we hope you will be able to attend this conference in 2023.
The main objective of the Vascular Cell Biology Gordon Research Conference is to provide an integrated platform for presentation and discussion of latest advances in vascular biology, as they relate to both health and disease. The program will include sessions on the rapidly advancing fields of vascular metabolism, cellular heterogeneity, vascular cellular cross talk, as well as vascular development and specification, the role of the vasculature in inflammation, and vascular mechanobiology. Focus will be placed on relevance to human disease, including cardiovascular, neurovascular, and neoplastic pathogenesis. Nascent technologies will be highlighted. Interactive poster sessions will allow all participants to showcase their work, and short talks will be selected from the abstracts. Poster presenters will have the opportunity for rapid "poster preview" presentations during morning sessions to advertise their posters. Financial support will be available for travel for both junior and senior investigators.